Kindlin-2 inhibits TNF/NF-κB-Caspase 8 pathway in hepatocytes to maintain liver development and function.
Huanqing GaoYiming ZhongLiang ZhouSixiong LinXiaoting HouZhen DingYan LiQing YaoHuiling CaoXuenong ZouDi ChenXiao-Chun BaiGuozhi XiaoPublished in: eLife (2023)
Inflammatory liver diseases are a major cause of morbidity and mortality worldwide; however, underlying mechanisms are incompletely understood. Here we show that deleting the focal adhesion protein Kindlin-2 expression in hepatocytes using the Alb-Cre transgenic mice causes a severe inflammation, resulting in premature death. Kindlin-2 loss accelerates hepatocyte apoptosis with subsequent compensatory cell proliferation and accumulation of the collagenous extracellular matrix, leading to massive liver fibrosis and dysfunction. Mechanistically, Kindlin-2 loss abnormally activates the tumor necrosis factor (TNF) pathway. Blocking activation of the TNF signaling pathway by deleting TNF receptor or deletion of Caspase 8 expression in hepatocytes essentially restores liver function and prevents premature death caused by Kindlin-2 loss. Finally, of translational significance, adeno-associated virus mediated overexpression of Kindlin-2 in hepatocytes attenuates the D-galactosamine and lipopolysaccharide-induced liver injury and death in mice. Collectively, we establish that Kindlin-2 acts as a novel intrinsic inhibitor of the TNF pathway to maintain liver homeostasis and may define a useful therapeutic target for liver diseases.
Keyphrases
- rheumatoid arthritis
- oxidative stress
- liver injury
- signaling pathway
- cell proliferation
- extracellular matrix
- drug induced
- poor prognosis
- cell death
- liver fibrosis
- pi k akt
- induced apoptosis
- binding protein
- metabolic syndrome
- lps induced
- endoplasmic reticulum stress
- epithelial mesenchymal transition
- cell cycle
- escherichia coli
- early onset
- adipose tissue
- cystic fibrosis
- immune response
- cell cycle arrest
- insulin resistance